User profiles for Molly Franke
 | Molly FrankeHarvard Medical School; Partners In Health Verified email at hms.harvard.edu Cited by 4876 |
[HTML][HTML] Comprehensive treatment of extensively drug-resistant tuberculosis
…, CA Bonilla, K Chalco, S Choi, MF Franke… - … England Journal of …, 2008 - Mass Medical Soc
Background Extensively drug-resistant tuberculosis has been reported in 45 countries,
including countries with limited resources and a high burden of tuberculosis. We describe the …
including countries with limited resources and a high burden of tuberculosis. We describe the …
Validity and utility of the Patient Health Questionnaire (PHQ)‐2 and PHQ‐9 for screening and diagnosis of depression in rural Chiapas, Mexico: A cross‐sectional …
…, J Mukherjee, D Palazuelos, MF Franke - Journal of clinical …, 2017 - Wiley Online Library
Background Depressive disorders are frequently under diagnosed in resource‐limited settings
because of lack of access to mental health care or the inability of healthcare providers to …
because of lack of access to mental health care or the inability of healthcare providers to …
Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment
MF Franke, SC Appleton, J Bayona… - Clinical infectious …, 2008 - academic.oup.com
Background. Completing treatment for multidrug-resistant (MDR) tuberculosis (TB) may be
more challenging than completing first-line TB therapy, especially in resource-poor settings. …
more challenging than completing first-line TB therapy, especially in resource-poor settings. …
Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda
Background: Access to antiretroviral therapy (ART) has rapidly expanded; as of the end of
2010, an estimated 6.6 million people are receiving ART in low-income and middle-income …
2010, an estimated 6.6 million people are receiving ART in low-income and middle-income …
Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study
MC Becerra, SC Appleton, MF Franke, K Chalco… - The Lancet, 2011 - thelancet.com
Background Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis have
emerged as major global health threats. WHO recommends contact investigation in close …
emerged as major global health threats. WHO recommends contact investigation in close …
Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda
MF Franke, F Kaigamba, AR Socci… - Clinical Infectious …, 2013 - academic.oup.com
Background. Minimizing death and ensuring high retention and good adherence remain
ongoing challenges for human immunodeficiency virus (HIV) treatment programs. We examined …
ongoing challenges for human immunodeficiency virus (HIV) treatment programs. We examined …
[HTML][HTML] Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis
…, G Davaasambuu, WW Fawzi, MF Franke… - PLoS …, 2019 - journals.plos.org
Background Few studies have evaluated the association between preexisting vitamin D
deficiency and incident tuberculosis (TB). We assessed the impact of baseline vitamins D levels …
deficiency and incident tuberculosis (TB). We assessed the impact of baseline vitamins D levels …
Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment
Rationale: Extensively drug-resistant (XDR) tuberculosis (TB) may arise in individuals on
treatment for multidrug-resistant (MDR) TB. Preventing this amplification of resistance will likely …
treatment for multidrug-resistant (MDR) TB. Preventing this amplification of resistance will likely …
Implementation of GenoType MTBDRplus Reduces Time to Multidrug-Resistant Tuberculosis Therapy Initiation in South Africa
…, D Theron, EA Kendall, MF Franke… - Clinical infectious …, 2013 - academic.oup.com
Background. Diagnosis of drug resistance and timely initiation of multidrug-resistant (MDR)
tuberculosis therapy are essential to reduce transmission and improve patient outcomes. We …
tuberculosis therapy are essential to reduce transmission and improve patient outcomes. We …
Safety of treatment regimens containing bedaquiline and delamanid in the endTB cohort
Background Safety of treatment for multidrug-resistant tuberculosis (MDR/RR-TB) can be an
obstacle to treatment completion. Evaluate safety of longer MDR/RR-TB regimens …
obstacle to treatment completion. Evaluate safety of longer MDR/RR-TB regimens …